STING1 and cancer: The IFN-1 signaling pathway, mediated by the regulation of interferon-stimulated genes (ISGs) in cancer, plays a crucial role in modulating the TME, regulating the anti-tumor immune response, and influencing therapy sensitivity [14,15].